ImmunoBiochem Partners with Centre for Commercialization of Antibodies and Biologics

Ontario Industry Updates
Written By Guest User

ImmunoBiochem has received an investment from, and entered a new co-development partnership with the Centre for Commercialization of Antibodies and Biologics (CCAB). The goal of the agreement is to develop ImmunoBiochem’s lead candidate towards regulatory filings.

Click here for more info.

Guest User
Previous

Join the Ontario Trade Mission at the Biotech Showcase 2019 in San Francisco
Next

York University Announces Artificial Intelligence Industry Partnership Fund